Living conditions and autonomy levels in COPD patients receiving non-invasive ventilation: impact on health related quality of life.
COPD
Impairment of autonomy
Non-invasive ventilation
Quality of life
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
03 Aug 2021
03 Aug 2021
Historique:
received:
05
05
2021
accepted:
07
07
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Research on health-related quality of life (HRQL) has become increasingly important in recent decades. However, the impact of both living conditions and the level of autonomy impairments on HRQL in COPD patients receiving non-invasive ventilation (NIV) is still unclear. The Severe Respiratory Insufficiency Questionnaire (SRI) was used to measure HRQL in a prospective cohort of COPD patients in whom home NIV was already established. Data on sociodemographics, clinical characteristics and standardized levels of autonomy impairment were evaluated. A multiple linear regression analysis was performed to identify the factors associated with a reduced HRQL. A total of 137 patients (67.0 ± 7.8 years, 45% female) were assessed. The mean SRI Summary Score was 54.1 ± 16.9 (95%CI: 51.1-57.1; N = 127). Regular ambulatory care was provided in 76% of patients, but only 37% underwent pulmonary rehabilitation. Overall, 69% of patients lived with family members, while 31% lived alone (family situation). Autonomy impairment levels were most serious in 3%, serious in 14%, and significant in 29% of patients, while 54% had no impairments at all. Of note, higher levels of autonomy impairment were markedly associated with lower SRI scores (regression coefficient - 6.5 ± 1.1 per level; P < 0.001). In contrast, family situation (0.2 ± 3.0; P = 0.959), ambulatory care by a respiratory specialist (1.7 ± 3.6; P = 0.638), and pulmonary rehabilitation (- 0.8 ± 3.1; P = 0.802) did not appear to influence HRQL. Possible subgroup effects were evident for the factors "impaired autonomy" and "living in a nursing home" (P = 0.016). A higher level of autonomy impairment has been identified as the major determinant of reduced HRQL in COPD-patients receiving long-term NIV, particularly in those living in a nursing home. Trial Registration German Clinical Trials Register (DRKS00008759).
Sections du résumé
BACKGROUND
BACKGROUND
Research on health-related quality of life (HRQL) has become increasingly important in recent decades. However, the impact of both living conditions and the level of autonomy impairments on HRQL in COPD patients receiving non-invasive ventilation (NIV) is still unclear.
METHODS
METHODS
The Severe Respiratory Insufficiency Questionnaire (SRI) was used to measure HRQL in a prospective cohort of COPD patients in whom home NIV was already established. Data on sociodemographics, clinical characteristics and standardized levels of autonomy impairment were evaluated. A multiple linear regression analysis was performed to identify the factors associated with a reduced HRQL.
RESULTS
RESULTS
A total of 137 patients (67.0 ± 7.8 years, 45% female) were assessed. The mean SRI Summary Score was 54.1 ± 16.9 (95%CI: 51.1-57.1; N = 127). Regular ambulatory care was provided in 76% of patients, but only 37% underwent pulmonary rehabilitation. Overall, 69% of patients lived with family members, while 31% lived alone (family situation). Autonomy impairment levels were most serious in 3%, serious in 14%, and significant in 29% of patients, while 54% had no impairments at all. Of note, higher levels of autonomy impairment were markedly associated with lower SRI scores (regression coefficient - 6.5 ± 1.1 per level; P < 0.001). In contrast, family situation (0.2 ± 3.0; P = 0.959), ambulatory care by a respiratory specialist (1.7 ± 3.6; P = 0.638), and pulmonary rehabilitation (- 0.8 ± 3.1; P = 0.802) did not appear to influence HRQL. Possible subgroup effects were evident for the factors "impaired autonomy" and "living in a nursing home" (P = 0.016).
CONCLUSION
CONCLUSIONS
A higher level of autonomy impairment has been identified as the major determinant of reduced HRQL in COPD-patients receiving long-term NIV, particularly in those living in a nursing home. Trial Registration German Clinical Trials Register (DRKS00008759).
Identifiants
pubmed: 34344338
doi: 10.1186/s12890-021-01621-4
pii: 10.1186/s12890-021-01621-4
pmc: PMC8330117
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
255Informations de copyright
© 2021. The Author(s).
Références
Eur Respir J. 2010 May;35(5):955-7
pubmed: 20436171
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Thorax. 2009 Aug;64 Suppl 2:ii1-26
pubmed: 19586968
J Clin Epidemiol. 2003 Aug;56(8):752-9
pubmed: 12954467
Respir Care. 2016 Sep;61(9):1186-91
pubmed: 27118875
Arch Bronconeumol. 2017 Mar;53(3):128-149
pubmed: 28274597
Lancet Respir Med. 2014 Sep;2(9):698-705
pubmed: 25066329
Respiration. 2018;96(2):171-203
pubmed: 29945156
Respiration. 2018;95(3):154-160
pubmed: 29232680
Thorax. 2014 Sep;69(9):826-34
pubmed: 24781217
Eur Respir J. 2010 May;35(5):1064-71
pubmed: 19717483
Respiration. 2017;93(4):253-263
pubmed: 28142139
Eur Respir Rev. 2013 Dec;22(130):454-75
pubmed: 24293462
Ann Intensive Care. 2018 Mar 16;8(1):38
pubmed: 29549456
BMC Pulm Med. 2020 Aug 17;20(1):221
pubmed: 32807149
Chest. 2020 Jul;158(1):279-291
pubmed: 32243941
Pulm Pharmacol Ther. 2014 Apr;27(2):129-38
pubmed: 24468677
J Clin Epidemiol. 2015 Nov;68(11):1375-9
pubmed: 26146089
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Clin Epidemiol. 2008 Aug;61(8):848-53
pubmed: 18367376
Respiration. 2015;89(4):312-21
pubmed: 25791249
ERJ Open Res. 2018 Apr 09;4(2):
pubmed: 29637078
Respir Res. 2011 Aug 23;12:112
pubmed: 21861914
Eur Respir J. 2019 Sep 28;54(3):
pubmed: 31467119
Expert Rev Respir Med. 2021 Jan;15(1):89-101
pubmed: 33245003
Eur Respir J. 2008 Nov;32(5):1328-36
pubmed: 18579546
JAMA. 2020 Feb 4;323(5):455-465
pubmed: 32016309
Respiration. 2018;96(1):66-97
pubmed: 29945148
Pneumologie. 2020 Dec;74(12):813-841
pubmed: 33291162
JAMA. 2017 Jun 6;317(21):2177-2186
pubmed: 28528348